 |
Articles: Research & Development |
Prior Articles
Novartis on track to deliver Influenza A (H1N1) vaccine for the US
Novartis, 10/30/09
Free full text
Sanofi-aventis and US biopharmaceutical company Micromet sign global collaboration and license agreement for new solid tumor BiTE antibody
Sanofi-aventis, 10/30/09
Free full text
PhRMA Statement on House Health Care Reform Bill
PhRMA, 10/30/09
Free full text
Health Care in Canada 2009: A Decade in Review
Canadian Institute for Health Information, 10/30/09
Free full text
CCHIT Seeks Trustees, Commissioners
HealthDataManagement, 10/30/09 KLAS Assesses Document Mgmt. Apps
HealthDataManagement, 10/30/09 Glossary of Genetic Terms Gets Upgrade
HealthDataManagement, 10/30/09 AHA Endorses Incident Mgmt. App
HealthDataManagement, 10/30/09 Patients taking VIMOVO showed improved UGI tolerability assessments as compared to EC naproxen
AstraZeneca, 10/29/09
Free full text
Nabi Biopharmaceuticals Participates in NicVAX(R) Phase IIb Study
Nabi Biopharmaceuticals, 10/29/09
Free full text
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
Forest Laboratories, 10/29/09
Free full text
New Study Results Analyzed the Use of KAPIDEX for Nighttime Heartburn in Adults with Non-Erosive GERD
Takeda Pharmaceuticals North America, 10/28/09 Melody Transcatheter Valve Demonstrates Encouraging Results in Study on Patients with Congenital Heart Disease
Medtronic, 10/28/09
Free full text
Pandemic 2009 Influenza Update: Pandemrix? data in an elderly population
GlaxoSmithKline, 10/28/09
Free full text
Phase 2 data from oral NKTR-118 presented at American College of Gastroenterology in San Diego
AstraZeneca, 10/28/09
Free full text
GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD
GlaxoSmithKline, 10/28/09
Free full text
Epocrates Boosts Blackberry Support
HealthDataManagement, 10/28/09 New Study on Vyvanse (lisdexamfetamine dimesylate) Capsules CII Shows Administration of Vyvanse Through Two Different Routes Demonstrated a Similar Pharmacokinetic Profile
Shire, 10/27/09 For Parents of Kids with Food Allergies, the Scariest Thing at Halloween is the Trick-or-Treat Bag
Mylan, 10/27/09 Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Cephalon, 10/27/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
